Comparison of ATG to Thymoglobuline in Renal Transplantation
Status:
Completed
Trial end date:
2015-02-01
Target enrollment:
Participant gender:
Summary
An open, multicenter, randomised, parallel group pilot study to investigate two different
polyclonal rabbit immunoglobulin preparations for safety and efficacy: A comparison of
ATG-Fresenius S to Thymoglobulin in prophylaxis for immunological high risk patients
following renal transplantation. This non-inferiority trial shall demonstrate that
ATG-Fresenius S is as efficacious as Thymoglobulin but has a better tolerance and fewer side
effects.